Association of aspirin use with major bleeding in patients with and without diabetes.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2012-06-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2012.5034PMID 22706834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temporal trends of the gaps in post-myocardial infarction secondary prevention strategies of co-morbid and elderly populations vs. younger counterparts: an analysis of three successive cohorts between 2003 and 2008.

  2012cited by this paper
• The burden of hospitalization related to diabetes mellitus: a population-based study.

  2012cited by this paper
• Cost-utility of aspirin and proton pump inhibitors for primary prevention.

  2011cited by this paper
• Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis

  2011cited by this paper
• Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study

  2011cited by this paper
• Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta‐analysis

  2010cited by this paper
• Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation

  2010cited by this paper
• Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

  2010cited by this paper
• Do statins protect against upper gastrointestinal bleeding?

  2009cited by this paper
• Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

  2009cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2009cited by this paper
• Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

  2009cited by this paper
• Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

  2009cited by this paper
• Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.

  2009cited by this paper
• Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk

  2009cited by this paper
• COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.

  2009cited by this paper
• Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction

  2008cited by this paper
• De testimonio: on the evidence for decisions about the use of therapeutic interventions.

  2008cited by this paper
• ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

  2008cited by this paper
• ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

  2008cited by this paper
• A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study

  2007cited by this paper
• Low-dose aspirin and upper gastrointestinal damage:epidemiology, prevention and treatment

  2007cited by this paper
• The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure

  2007cited by this paper
• Hospitalization for gastrointestinal adverse events attributable to the use of low‐dose aspirin among patients 50 years or older also using non‐steroidal anti‐inflammatory drugs: a retrospective cohort study

  2007cited by this paper
• High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

  2007cited by this paper
• Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological study.

  2007cited by this paper
• Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.

  2006cited by this paper
• Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials.

  2006cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• Low-dose aspirin for the prevention of atherothrombosis.

  2005cited by this paper
• Estimating causal effects of public health education campaigns using propensity score methodology

  2005cited by this paper
• Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies

  2005cited by this paper
• Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan.

  2005cited by this paper
• Stroke Prevention by Aggressive Reduction in Cholesterol Levels

  2004cited by this paper
• Risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin for the prevention of cardiovascular diseases

  2002cited by this paper
• Comparative Analysis of Record Linkage Decision Rules

  2002cited by this paper
• Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies.

  2001cited by this paper
• Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques

  2001cited by this paper
• Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.

  2000cited by this paper
• Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

  2000cited by this paper
• Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs

  2000cited by this paper
• Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

  1998cited by this paper

• Polypharmacy and Drug-Drug Interactions in Elderly Patients With Gastrointestinal Bleeding: A Single-Center Retrospective Study

  2025cites this paper
• HypKG: Hypergraph-based Knowledge Graph Contextualization for Precision Healthcare

  2025cites this paper
• The Effects of Statin Therapy on Mean Platelet Volume in Patients with Cardiovascular Diseases

  2025cites this paper
• Functional Disability After Clinically Significant Extracranial Bleeding: a secondary analysis of ASPREE.

  2025cites this paper
• Repurposing salicylic acid as a versatile inducer of proximity

  2025cites this paper
• Association of cardiometabolic risk burden with gastrointestinal bleeding in aspirin users

  2025cites this paper
• Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial

  2025cites this paper
• Natural language processing for identifying major bleeding risk in hospitalised medical patients

  2025cites this paper
• Efficacy and Safety of Dual Antiplatelet Treatment up to 72 Hours in Acute Ischemic Stroke Stratified by Glycemic Status

  2025cites this paper
• Α 6-month, multicenter, observational study investigating the treatment of venous thromboembolism in Greece (VICTORIA study)

  2025cites this paper
• Antiplatelet Therapy in Myocardial Bridge: Insights From the RIALTO Registry

  2025cites this paper
• Intractable epistaxis requiring surgical exploration or arterial embolization; Associated comorbidities and locations of the bleeder.

  2024cites this paper
• Aspirin-Induced Massive Spontaneous Sublingual Hematoma

  2024cites this paper
• Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis

  2024cites this paper
• Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low‐dose acetylsalicylic acid (ASA) compared with SSRI or low‐dose ASA alone—A systematic review and meta‐analysis

  2024cites this paper
• Appropriateness of aspirin use among diabetic patients in primary prevention of atherosclerotic cardiovascular diseases: an analysis of the ASSOS study.

  2023influential citation
• Risk of Bleeding and Venous Thromboembolism after Colorectal Cancer Surgery in Patients with and without Type 2 Diabetes: A Danish Cohort Study

  2023cites this paper
• Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial

  2023cites this paper
• Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management

  2023cites this paper
• Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV

  2023cites this paper
• Aspirin Use to Prevent Cardiovascular Disease.

  2022cites this paper
• Incidence and outcome of gastrointestinal bleeding in patients receiving aspirin with or without clopidogrel over 10 years- An observational study

  2022cites this paper
• Low-Dose Aspirin during Pregnancy and Postpartum Bleeding

  2022cites this paper
• Questions and Answers on the Use of Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes.

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.

  2022cites this paper
• Gastrointestinal Bleeding Risk Factors in Patients with Type 2 Diabetes Mellitus.

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.

  2022cites this paper
• New approaches of antiplatelet therapy in the prevention of cardiovascular diseases

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• Effect of fruitflow on platelet function: A randomized placebo-controlled clinical trial in middle-aged and elderly subjects

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

  2022cites this paper
• Novel Glibenclamide–Phospholipid Complex for Diabetic Treatment: Formulation, Physicochemical Characterization, and in-vivo Evaluation

  2022cites this paper
• Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study

  2022cites this paper
• Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort

  2022cites this paper
• Identification of Preoperative Clinical Factors Associated With Perioperative Blood Transfusions

  2021cites this paper
• Moving from dual antiplatelet therapy to monotherapy based on P2Y12 receptor blockade—why it could be a novel paradigm?

  2021cites this paper
• Spontaneous Preterm Birth: Is Prevention with Aspirin Possible?

  2021cites this paper
• Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

  2021cites this paper
• Aspirin in the Prevention of Cardiovascular Disease and Cancer.

  2021cites this paper
• External Validation of the Renal Ablation-Specific (MC)2 Risk Scoring System in Predicting Complications from Percutaneous Renal Cryoablation

  2021cites this paper
• Risk of Postoperative Gastrointestinal Bleeding and Its Associated Factors: A Nationwide Population-Based Study in Korea

  2021cites this paper
• Vascular disease prevention and screening in women

  2021cites this paper
• Curcumin Acetylsalicylate Extends the Lifespan of Caenorhabditis elegans

  2021cites this paper
• Who Are the Doctors of Korean Medicine? Exploring the Identity of a Medical Profession

  2021cites this paper
• Benefits of Ticagrelor Plus Aspirin According to Diabetes-Related Factors: A Complex Equation.

  2021cites this paper
• Aspirin prescribing pattern and guidelines-adherence evaluation for primary prevention of cardiovascular diseases at a teaching hospital

  2021cites this paper
• A RETROSPECTIVE COHORT STUDY ON THE RISK FACTORS OF GASTROINTESTINAL BLEEDING IN ACUTE ISCHEMIC STROKE PATIENTS WITH ATRIAL FIBRILLATION

  2021cites this paper
• Big Data Analysis of the Risk of Intracranial Hemorrhage in Korean Populations Taking Low-Dose Aspirin.

  2021cites this paper
• Evaluation of low-dose aspirin use among COVID-19 critically ill patients: A Multicenter Propensity Score Matched Study

  2021cites this paper
• The Evidence of Aspirin Use in Prevention of Adverse Pregnancy Outcomes (APOs): Should It Be Continued Long Term After an APO?

  2021cites this paper
• Analysis of the Occurrence of Major Hemorrhagic Incidents in Patients with Low-Dose Aspirin Usage in Korean Populations – Does Low-Dose Aspirin Really Increase the Risk of Bleeding?

  2020cites this paper
• All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study

  2020cites this paper
• Prediction of perioperative transfusions using an artificial neural network

  2020cites this paper
• Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes mellitus: A meta-analysis of randomized controlled trials

  2020cites this paper
• Ácido acetilsalicílico para la prevención primaria de eventos cardiovasculares

  2020cites this paper
• Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders

  2020cites this paper
• Association of baseline hemoglobin A1c levels with bleeding in patients with non-ST-segment elevation acute coronary syndrome underwent percutaneous coronary intervention: insights of a multicenter cohort study from China

  2020cites this paper
• Inhibitory effect of Fruitflow on platelet function: a randomized placebo-controlled trial in elderly subjects

  2020cites this paper
• The Risk of Gastrointestinal Hemorrhage in Low-Dose Aspirin Users with Diabetes Mellitus: Systematic Review and Meta-Analysis

  2020cites this paper
• A Pathophysiologic Primary Prevention Review of Aspirin Administration to Prevent Cardiovascular Thrombosis.

  2020cites this paper
• Peptic Ulcer—Duodenal and Gastric

  2020cites this paper
• Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.

  2020cites this paper
• Risk of Intracranial Hemorrhage With Concomitant Use of Antidepressants and Nonsteroidal Anti-inflammatory Drugs: A Nested Case-Control Study

  2020cites this paper
• Cardiovascular mortality and morbidity burden in successive and age pre-stratified case–control cohorts of breast cancer women. A population-based study

  2020cites this paper
• Influence of Sex on Platelet Reactivity in Response to Aspirin

  2020cites this paper
• Aspirin use during pregnancy and the risk of bleeding complications: A Swedish population-based cohort study.

  2020cites this paper
• Impact of Body Mass Index on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Thermal Ablation for Renal Cell Carcinoma.

  2020cites this paper
• [Choosing Antithrombotic Therapy in Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus: How to Reduce the Risk of Death].

  2020cites this paper
• Thermal Ablation of Renal Cell Carcinoma in Morbidly Obese Patients: Assessment of Technical Results, Procedural Safety, and Oncological Outcomes.

  2020cites this paper
• Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.

  2020cites this paper
• Pre-eclampsia screening in the first trimester – preemptive action to prevent the peril

  2020cites this paper
• The effect of inorganic nitrate and antiplatelet drugs on NO metabolites and platelet reactivity in patients with stable coronary artery disease

  2019cites this paper
• Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease

  2019cites this paper
• Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (from MESA).

  2019cites this paper
• A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study.

  2019cites this paper
• Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy

  2019cites this paper
• Inhibition of mPGES-1 as therapeutic strategy in inflammation and cancer

  2019cites this paper
• Aspirin for Primary Prevention of Cardiovascular Events.

  2019cites this paper
• Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence

  2019cites this paper
• Antiplatelet agents for preventing pre-eclampsia and its complications.

  2019cites this paper
• Sex differences in adverse drug events from cardiovascular medicines in routine care

  2019cites this paper
• Aspirin for Primary Prevention of Cardiovascular Disease

  2019cites this paper
• Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer.

  2019cites this paper
• Aspirin for primary prevention of stroke in traumatic cerebrovascular injury: association with increased risk of transfusion.

  2019cites this paper
• Impact of Discontinuation of Antithrombotic Therapy Following Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.

  2019cites this paper
• Low-Dose Aspirin Use During Pregnancy

  2018cites this paper
• Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore

  2018cites this paper
• Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

  2018cites this paper
• Development of a standardized de nition for clinically signi cant bleeding fi fi in the ASPirin in Reducing Events in the Elderly ( ASPREE ) trial

  2018cites this paper
• Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs

  2018cites this paper
• Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.

  2018cites this paper
• Effect of Secondary Prevention Educational Guidelines on Patients ’ Clinical Outcomes Post Endoscopic Ligation of Esophageal Varies

  2018cites this paper
• Aspirin Use and Mortality in Two Contemporary US Cohorts

  2018cites this paper
• Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study

  2018cites this paper
• Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials.

  2018cites this paper
• Aspirinle primer koruma kimlere yapalım

  2018cites this paper
• Prediction and prevention of pre‐eclampsia in Asian subpopulation

  2018cites this paper
• Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

  2018cites this paper
• 24 – Managing Chronic Coronary Artery Disease in Patients with Diabetes

  2018cites this paper
• Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial

  2018cites this paper